Translational Oncology

Translational oncology bridges laboratory research and patient care. It is the process of turning biological insights into the clinic and clinical questions back into research so that discoveries about how cancers arise, evolve, and respond to treatment can be translated into better diagnosis, more precise treatment, and improved outcomes for patients.

At the Department of Pathology, translational oncology is central to what we do. Because we combine detailed knowledge of the clinical and molecular characteristics of a wide range of cancers, our department is uniquely placed to connect the laboratory and the clinic. Working closely with clinical, genetic, and molecular diagnostics colleagues, our research groups study how tumours develop and interact with the immune system, and how this knowledge can be used to guide patient care. Using patient-derived tissue and advanced technologies including next-generation sequencing, molecular profiling, and immunogenomic and systems-level approaches we aim to translate a deeper understanding of cancer into tangible benefit for patients.